Wellgistics Health Completes Reverse Split

Wellgistics Health (NASDAQ:WGRX) completed a 1-for-50 reverse stock split of its common shares, effective 12:01 a.m. ET on May 26, 2026.

Rhea-AI Summary

Wellgistics Health (NASDAQ:WGRX) completed a 1-for-50 reverse stock split of its common shares, effective 12:01 a.m. ET on May 26, 2026. The stock now trades under a new CUSIP.

The split reduced outstanding common shares from about 125,671,251 to approximately 2,513,425 and is intended to raise the share price to help regain compliance with Nasdaq’s minimum bid price requirement. Fractional shares were rounded up to the nearest whole share.

Positive

• Reverse split ratio of 1-for-50 completed on May 26, 2026
• Outstanding shares cut from about 125.7M to roughly 2.5M
• Action is intended to support regaining Nasdaq minimum bid price compliance
• Fractional shares from the split were rounded up to whole shares

Negative

• Company needs to regain compliance with Nasdaq minimum bid price rules

Argus May 26 session

-7.62% close to close Open Argus

Details

News Market Reaction – WGRX

In the May 26 session, WGRX declined 7.62%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -7.6% in the session following this news. A negative reaction despite the mechanical...

Analysis

The stock moved -7.6% in the session following this news. A negative reaction despite the mechanical nature of the reverse split fits prior trading around this capital-structure change, where the earlier announcement drew selling pressure. The completed 1-for-50 action does not alter fundamentals by itself but may refocus attention on listing compliance, financing needs, and the sizeable $200,000,000 shelf capacity. Such factors could reinforce concerns about future dilution and the company’s stressed balance sheet.

Key Figures

Reverse split ratio: 1-for-50 Post-split shares: 2,513,425 shares Pre-split shares: 125,671,251 shares +5 more

Reverse split ratio

1-for-50

Common stock reverse split completed May 26, 2026

Post-split shares

2,513,425 shares

Common shares outstanding after reverse split

Pre-split shares

125,671,251 shares

Approximate common shares outstanding before reverse split

Par value

$0.00001 per share

Par value of common stock referenced in split announcement

Effective time

12:01 a.m. ET

Legal effectiveness time of reverse split on May 26, 2026

Price change pre-news

-22.71%

24h move prior to reverse split completion announcement

52-week high

$2.56

Pre-news 52-week high versus current $0.0827 price

Shelf registration amount

$200,000,000

Maximum securities under April 15, 2026 S-3 shelf

Previous Stock split Reports

1 past event · Latest: May 20

Same Type 1 event

1. May 20

   Reverse stock split

   24h Move

   -17.1%

   Announcement and approval timing of 1-for-50 reverse split for Nasdaq compliance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

reverse stock split, cusip, nasdaq capital market, minimum bid price requirement

4 terms

reverse stock split financial

"today announced that it completed a 1-for-50 reverse stock split (the "Reverse Split")"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

cusip regulatory

"The Common Stock is now trading under a new CUSIP number."

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

View in glossary

nasdaq capital market regulatory

"continued listing on The Nasdaq Capital Market."

The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.

minimum bid price requirement regulatory

"to regain compliance with the minimum bid price requirement for continued listing"

A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

• 1-for-50 reverse split of common shares outstanding now complete

• 2,513,425 common shares now outstanding

• A new CUSIP was issued in connection with reverse split

TAMPA, FL / ACCESS Newswire / May 26, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that it completed a 1-for-50 reverse stock split (the "Reverse Split") of the Company's common stock, par value $0.00001 per share (the "Common Stock"). The Reverse Split was approved by a majority of the stockholders of the Company on April 2, 2026. The Common Stock is now trading under a new CUSIP number.

The Reverse Split legally took effect at 12:01 a.m. Eastern Time, on May 26, 2026. The Reverse Split is intended to increase the per share trading price of the Common Stock to enable the Company to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.

The 1-for-50 Reverse Split automatically converted every 50 previous shares of the Company's Common Stock into one share of Common Stock. No fractional shares were issued in connection with the Reverse Split. Any fractional share of Common Stock that would otherwise result from the Reverse Split was rounded up to the nearest whole share.

The Reverse Split reduced the number of shares of outstanding Common Stock from approximately 125,671,251 to approximately 2,513,425 shares of Common Stock.

About Wellgistics Health, Inc.

Wellgistics Health (NASDAQ:WGRX) is a Health IT leader integrating its proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx™ into its blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription drug dispensing journey. Its integrated platform connects more than 6,500 pharmacies and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility verification, onboarding, adherence support, prior authorization, and cash-pay fulfillment designed to improve patient access and transparency across the prescription ecosystem.

For more information, visit www.wellgisticshealth.com.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements regarding the Company's intent or ability to regain compliance with Nasdaq's minimum bid price requirement, the expected effect of the reverse stock split on the per share trading price of the Company's common stock, and the Company's continued listing on The Nasdaq Capital Market. Forward-looking statements are based on current expectations, estimates and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including, among others, risks relating to fluctuations in the market price of the Company's common stock, the Company's ability to satisfy Nasdaq's continued listing requirements, market and trading conditions, the impact of the reverse stock split on investor interest and liquidity in the Company's common stock, and other risks described in the Company's filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Wellgistics Media & Investor Contact
Media: media@wellgisticshealth.com
Investor Relations: IR@wellgisticshealth.com

SOURCE: Wellgistics Health, Inc.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What reverse stock split did Wellgistics Health (WGRX) complete on May 26, 2026?

Wellgistics Health completed a 1-for-50 reverse stock split of its common stock. According to Wellgistics, every 50 previously outstanding shares were automatically converted into one share, with no fractional shares issued and any fractions rounded up to a whole share.

How many Wellgistics Health (WGRX) shares are outstanding after the 2026 reverse split?

After the reverse split, Wellgistics has about 2,513,425 common shares outstanding. According to Wellgistics, this reflects a reduction from approximately 125,671,251 shares before the split, achieved through the automatic 1-for-50 conversion ratio applied to all common stock.

When did the Wellgistics Health (WGRX) reverse split become effective?

The reverse stock split became legally effective at 12:01 a.m. Eastern Time on May 26, 2026. According to Wellgistics, the common stock now trades on Nasdaq under a new CUSIP number that reflects the completion of this corporate action.

Why did Wellgistics Health (WGRX) implement a 1-for-50 reverse stock split?

Wellgistics implemented the reverse split to help increase its per share trading price. According to Wellgistics, the goal is to enable the company to regain compliance with the Nasdaq Capital Market minimum bid price requirement for continued stock exchange listing.

How are fractional shares handled in the Wellgistics Health (WGRX) reverse split?

No fractional shares are being issued in the reverse split. According to Wellgistics, any fractional common share that would otherwise result from applying the 1-for-50 ratio is rounded up to the nearest whole share for affected shareholders.

Did Wellgistics Health (WGRX) shareholders approve the 2026 reverse split?

Yes, the reverse stock split was approved by a majority of shareholders. According to Wellgistics, stockholders authorized the 1-for-50 reverse split of common stock on April 2, 2026, enabling the company to proceed with the capital structure change.

Did Wellgistics Health (WGRX) receive a new CUSIP after the reverse split?

Yes, WGRX now trades under a new CUSIP number following the reverse split. According to Wellgistics, the new CUSIP was issued in connection with the 1-for-50 reverse stock split of the company’s common stock completed on May 26, 2026.